AGL 2043
AGL 2043 is a reversible and ATP-competitive small molecule inhibitor targeting type III receptor tyrosine kinases. It is utilized in biochemical and cellular assays to investigate kinase signaling pathways in oncology and cardiovascular research, as evidenced by its application in published in vitro studies.
Product Specifications
CAS Number
226717-28-8
Field of Research
Cancer Biology, Cardiovascular Research, Signal Transduction
Smiles
CN1C=2C (=CC=3C (C2) =NC=C (N3) C4=CC=CS4) N=C1C
Molecular Formula
C15H12N4S
Molecular Weight
280.35
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog